期刊文献+

STZ诱导的糖尿病鼠视网膜β-连环蛋白表达上调 被引量:3

Increased expression of β-catenin in the streptozotocin-induced diabetic rat retina
下载PDF
导出
摘要 目的:探讨链脲霉素(Streptozotocin,STZ)诱导的糖尿病鼠视网膜β-连环蛋白(β-catenin)表达以及与早期糖尿病视网膜病变发展的可能关系。方法:建立STZ诱导的糖尿病大鼠模型,用伊文思蓝检测视网膜血管的渗透性;免疫组织化学和Westernblot方法检测糖尿病鼠视网膜及胰蛋白酶消化的视网膜微血管β-连环蛋白的表达情况。结果:糖尿病诱导4、8和12wk后视网膜血管渗透性分别增加68%、91%和125(%P<0.005)。免疫组化分析证实对照组视网膜β-连环蛋白主要表达在视网膜光感受器、外网状层、内网状层、神经节细胞层、内界膜及视网膜微血管内皮细胞和周细胞。STZ诱导糖尿病大鼠12wk后,视网膜及视网膜微血管β-连环蛋白表达显著增加。West-ernblot分析证明随着糖尿病视网膜病变的发展,视网膜β-连环蛋白表达显著增加。结论:STZ诱导的糖尿病视网膜β-连环蛋白的表达增加,提示β-连环蛋白可能参与早期糖尿病视网膜病变的发生。 AIM: To study the expression of β -catenin in streptozotodn (STZ)-induced diabetic rat retina and the possible relevance of β -catenin in the early stage of STZ-induced diabetic retinopathy. METHODS: Vascular permeability was quantified by measuring albumin leakage from blood vessels into the retina using the Evans blue method. The model of STZ-induced diabetic rat was set up. β -catenin expression was measured in both normal and STZ-induced diabetic rat retinas and retinal microvessel using immunohistochemistry and Western blot analysis. RESULTS: Retinal vascular permeability was increased by 68%, 91% and 125% in the 4-, 8- and 12-weak diabetic retinas, respectively, compared with that in the controls (P 〈 0.005). Tmmunohistochemistry showed the expression of β-catanin was detected and localized to the photoceptor, outer plexiform layer, inner plexiform layer, ganglion cell layer, internal limiting membrane and microvessel of rat retinas. However, the expression of β -catenin was significantly increased in STZ-induced diabetic rat retinas with the progression of diabetes. CONCLUSION: The increased expression of β -catenin in the retinas of STZ-induced diabetic rat may reflect that β-catanin participates in the development of diabetic retinopathy.
出处 《国际眼科杂志》 CAS 2007年第1期57-60,共4页 International Eye Science
关键词 Β-连环蛋白 糖尿病 视网膜病变 STREPTOZOTOCIN β-catenin diabetes retinopathy streptozo-todn
  • 相关文献

参考文献2

二级参考文献8

共引文献36

同被引文献33

  • 1李养军,惠延年.高糖诱导牛视网膜微血管周细胞FOXO1A表达增加[J].国际眼科杂志,2007,7(2):373-376. 被引量:4
  • 2Frank RN.Diabetic retinopathy.N Engl J Med 2004;350(1):48-58.
  • 3Saaddine JB,Honeycutt AA,Narayan KM,et al.Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus:United States,2005-2050.Arch Ophthalmol 2008;126(12):1740-1747.
  • 4Funatsu H,Noma H,Mimura T,et al.Association of vitreous inflammatory factors with diabetic macular edema.Ophthalmology 2009;116(1):73-79.
  • 5Navaratna D,Menicucci G,Maestas J,et al.A peptide inhibitor of the urokinase / urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes.FASEB J 2008;22(9):3310-3317.
  • 6Resink TJ,Philippova M,Joshi MB,et al.Cadherins and cardiovascular disease.Swiss Med Wkly 2009;139(9-10):122-134.
  • 7Navaratna D,McGuire PG,Menicucci G,et al.Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.Diabetes 2007;56(9):2380-2387.
  • 8Schneeberger EE,Lynch RD.The tight junction:a multifunctional complex.Am J Physiol Cell Physiol 2004;286(6):C1213-1228.
  • 9Hammes HP,Lin J,Wagner P,et al.Angiopoietin-causes pericyte dropout in the normal retina:evidence for involvement in diabetic retinopathy.Diabetes 2004;53(4):1104-1110.
  • 10Essers MA,deVries LM,Barker N,et al.Functional interactiohn between β-catenin and FOXO in oxidative stress signaling.Science 2005;308(5725):1181-1184.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部